1-Benzyl 4-Methyl 4-Aminopiperidine-1,4-Dicarboxylate: Lab Protocol
1-Benzyl 4-Methyl 4-Aminopiperidine-1,4-Dicarboxylate: Lab Protocol
1-benzyl 4-methyl 4-aminopiperidine-1,4-dicarboxylate is a versatile, orthogonally protected 4-aminopiperidine building block widely employed in medicinal chemistry and fragment-based drug discovery as a conformationally rigid scaffold for constructing diverse N-heterocyclic pharmaceutical intermediates.
- SKU
- B172187
- IUPAC Name
- 1-benzyl 4-methyl 4-aminopiperidine-1,4-dicarboxylate
- Core Scaffold
- 4,4-disubstituted piperidine with orthogonal N-Cbz and C4-methyl ester protecting groups plus a free C4 primary amine
- Primary Application
- Intermediate in synthesis of drug candidates, peptidomimetics, and spirocyclic compounds
- Recommended Storage
- Cool, dry, well-ventilated location; away from heat, moisture, and incompatible materials
- Orthogonal Deprotection
- Cbz group removable by hydrogenolysis; methyl ester removable by saponification — enabling selective synthetic manipulation
Compound Overview and Chemical Properties
1-Benzyl 4-methyl 4-aminopiperidine-1,4-dicarboxylate (Aladdin SKU B172187) is a bifunctionally protected piperidine derivative bearing three distinct reactive handles: a benzyloxycarbonyl (Cbz) carbamate on the ring nitrogen, a methyl ester at the quaternary C4 carbon, and a free primary amine also at C4. This orthogonal protecting-group arrangement makes the compound a highly versatile synthon in complex molecule assembly.
The quaternary C4 center confers conformational rigidity to the piperidine ring, a property particularly valued in medicinal chemistry programs targeting G-protein-coupled receptors (GPCRs), kinases, and ion channels where three-dimensional shape complementarity to the binding pocket is critical. The compound serves as a key building block for spirocyclic intermediates, peptidomimetics, and a broad range of N-heterocyclic drug candidates.
Materials, Safety, and Pre-Protocol Preparation
Personal Protective Equipment (PPE): Lab coat, nitrile gloves, and safety goggles must be worn at all times. Work in a fume hood when handling solutions or performing reactions involving this compound.
Materials required:
- 1-Benzyl 4-methyl 4-aminopiperidine-1,4-dicarboxylate (B172187), quantity as needed
- Anhydrous organic solvents (e.g., DMF, DCM, THF, or MeOH) as appropriate for the intended reaction
- Reagents specific to the downstream transformation (acylating agents, reductive amination reagents, etc.)
- Analytical balance, volumetric glassware, magnetic stir plates
- Inert atmosphere setup (Schlenk line or glovebox) if moisture-sensitive reagents are used
Solubility guidance: The compound is expected to dissolve readily in polar aprotic solvents (DMF, DMSO) and chlorinated solvents (DCM, chloroform). Solubility in aqueous media is limited due to the lipophilic Cbz group; acidic aqueous conditions may protonate the amine to improve aqueous solubility for workup steps.
Storage: Store in a tightly sealed container in a cool, dry, well-ventilated area away from heat sources and moisture. Follow all institutional and regulatory guidelines for amine-containing reagents.
Step-by-Step Handling and Reaction Protocol
The following generic protocol describes how to handle B172187 as a starting material or intermediate. Adapt reagent choices and conditions to your specific synthetic target.
- Weighing: Tare a clean, dry vial or round-bottom flask on an analytical balance. Transfer the required amount of B172187 under ambient conditions or inert atmosphere as dictated by downstream reagents. Record the exact mass.
- Dissolution: Add the appropriate anhydrous solvent (typically DCM or DMF at 0.1–0.5 M concentration) to the weighed solid. Stir or swirl until complete dissolution is confirmed visually.
- Reaction setup — acylation of the free amine (example transformation): Cool the solution to 0 °C in an ice bath. Add 1.0–1.2 equivalents of the acylating agent (e.g., acid chloride or activated ester) dropwise, followed by 1.5–2.0 equivalents of a non-nucleophilic base (e.g., triethylamine or DIPEA). Allow to warm to room temperature and stir for 1–4 hours or until TLC/LCMS indicates complete consumption of starting material.
- Monitoring: Check reaction progress by TLC (suitable eluent: EtOAc/hexane or DCM/MeOH) or LCMS at appropriate intervals.
- Workup: Quench with saturated aqueous NH₄Cl or water. Extract with DCM (3×). Combine organic layers, wash with brine, dry over anhydrous Na₂SO₄ or MgSO₄, filter, and concentrate under reduced pressure.
- Purification: Purify crude product by silica gel column chromatography or preparative HPLC as required. Confirm identity and purity by ¹H NMR, ¹³C NMR, and HRMS.
- Cbz deprotection (if required): Dissolve the Cbz-protected intermediate in MeOH or EtOH. Add 10% Pd/C (catalytic, 5–10 wt%). Purge with H₂ gas (balloon pressure) and stir at room temperature for 2–6 hours. Filter through Celite and concentrate to yield the free piperidine nitrogen.
- Methyl ester hydrolysis (if required): Dissolve the ester in THF/H₂O (e.g., 3:1). Add 2–4 equivalents of LiOH·H₂O. Stir at room temperature for 2–12 hours. Acidify carefully to pH 3–4 and extract or lyophilize to obtain the carboxylic acid.
Record all observations, masses, volumes, and analytical data in a laboratory notebook contemporaneously.
Troubleshooting and Quality Control
Common issues and solutions:
- Incomplete dissolution: If the compound does not dissolve completely, gently warm the solvent (do not exceed 40 °C) or switch to a more polar solvent such as DMSO or DMF.
- Slow or incomplete acylation: Ensure the base is added in sufficient excess and that the acylating agent is fresh. Extend reaction time or increase temperature modestly. Confirm amine is not protonated by checking reaction pH.
- Incomplete Cbz deprotection: Replenish the H₂ atmosphere and extend reaction time. Ensure Pd/C catalyst is active (use a fresh batch if necessary). If substrate contains sulfur moieties, consider alternative deprotection methods to avoid catalyst poisoning.
- Ester hydrolysis over-reaction: Monitor carefully by TLC or LCMS. Use milder base (K₂CO₃ in MeOH/H₂O) if the product is base-sensitive.
Quality control checkpoints:
- Confirm identity of B172187 starting material by comparing ¹H NMR to literature or supplier certificate of analysis (CoA) data before use.
- Check TLC purity of intermediates at each stage.
- Submit final product for HRMS and NMR confirmation prior to biological testing or further synthetic steps.
Downstream Applications and Synthetic Utility
1-Benzyl 4-methyl 4-aminopiperidine-1,4-dicarboxylate (B172187) is used across a range of synthetic contexts:
- Amide coupling: The C4 primary amine reacts with activated carboxylic acids to form amide bonds, enabling incorporation of diverse pharmacophores onto the rigid piperidine scaffold.
- Reductive amination: The free amine can be condensed with aldehydes or ketones in the presence of a reducing agent (e.g., NaBH₃CN or NaBH(OAc)₃) to introduce secondary amine linkages.
- Spirocycle formation: Intramolecular cyclization reactions using the amine and ester handles can generate spirocyclic ring systems of interest in CNS drug discovery.
- Urea and carbamate synthesis: Reaction with isocyanates or chloroformates provides ureas or carbamates, expanding the structural diversity accessible from this building block.
- Sequential deprotection strategies: Selective removal of Cbz (hydrogenolysis) or methyl ester (saponification) allows independent elaboration of the nitrogen and carboxylate functionalities in a controlled sequence.
This compound exemplifies the utility of orthogonally protected piperidine scaffolds in enabling rapid, diverse analog synthesis in drug discovery campaigns.
Frequently asked questions
What solvents are recommended for dissolving 1-benzyl 4-methyl 4-aminopiperidine-1,4-dicarboxylate?
The compound is expected to dissolve well in polar aprotic solvents such as DMF and DMSO, and in chlorinated solvents such as DCM and chloroform. Solubility in purely aqueous media is limited due to the lipophilic Cbz protecting group; protonation of the amine under acidic aqueous conditions can improve water solubility during workup.
How do I selectively remove the Cbz group without affecting the methyl ester?
Cbz deprotection is typically achieved by hydrogenolysis using catalytic palladium on carbon (Pd/C) under hydrogen gas atmosphere in methanol or ethanol at room temperature. Methyl esters are stable under these conditions, enabling selective N-deprotection. Ensure the substrate and any other functional groups present are compatible with hydrogenation conditions before proceeding.
What is the significance of the quaternary C4 center in this piperidine building block?
The quaternary carbon at C4, bearing both the amino group and the methyl ester, locks the ring into a more rigid conformation compared to a non-quaternary piperidine. This conformational rigidity can improve binding selectivity and metabolic stability of derived drug candidates by reducing the entropic penalty upon target binding and limiting rotational freedom.
How should B172187 be stored to maintain stability?
Store B172187 in a tightly sealed container in a cool, dry, and well-ventilated location, away from heat, moisture, and incompatible materials. Follow all applicable institutional safety regulations for reagents containing both amine and ester functionality. Verify condition of the material against the certificate of analysis before use.
Can the methyl ester of B172187 be hydrolyzed independently of the Cbz group?
Yes. The methyl ester can be selectively hydrolyzed under basic aqueous conditions, typically using lithium hydroxide in THF/water or potassium carbonate in methanol/water, while the Cbz carbamate remains intact. Careful control of base strength, temperature, and reaction time is important to avoid over-hydrolysis or undesired Cbz cleavage.
References
- Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 4th ed.; Wiley-Interscience: New York, 2007.
- Roughley, S. D.; Jordan, A. M. The Medicinal Chemist's Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates. J. Med. Chem. 2011, 54, 3451–3479. doi:10.1021/jm200187y
- Aladdin Scientific. Certificate of Analysis for 1-Benzyl 4-Methyl 4-Aminopiperidine-1,4-Dicarboxylate, SKU B172187. Aladdin Scientific, Shanghai.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)